Price: $399.99 (Base Course)
Duration of Access: 30 Months
Deliverables: 12 Hours AAPA Category 1 Pharmacology Credit | 100 Hours AAPA Category 1 Credit (PANRE Review) | 1,672 Board-Style Questions
For many practicing physician assistants, June 30th is the final cutoff to secure pharmacology CME for mid-year reporting cycles and to use employer-provided 2026 CME stipends before they expire. While the NCCPA operates on a December 31st biennial cycle, many state licensing boards, employers, and hospital credentialing committees use a fiscal or mid-year deadline for license renewal, prescriptive authority documentation, or stipend reimbursement. If you wait until July, you may miss the window to apply this purchase toward your current cycle or current-year education funds.
Securing high-quality AAPA Category 1 Pharmacology Credit before June 30th is not just an administrative task; for many PAs, it is the last practical chance to lock in required pharmacology hours and spend remaining 2026 stipend dollars on eligible CME. If your funding resets on July 1 or your organization uses a mid-year budget deadline, this is the point where delay can cost you both credit progress and unused educational money.
The Pharmacology CME Review Package: Essential Clinical Updates
The Pharmacology CME Review Package is designed specifically for clinicians who require focused, evidence-based updates on pharmacotherapy. This course provides 12 hours of AAPA Category 1 Pharmacology Credit. If you still need pharmacology hours for a June 30th reporting, licensing, or employer deadline, this is the final window to secure them and apply eligible 2026 stipend funds before many mid-year budgets close. The content is curated by experienced physician assistants and is applicable to PAs, Nurse Practitioners, and physicians seeking Category 2 credit.
The curriculum covers a broad range of high-yield clinical topics including:
- Cardiovascular Pharmacology: Management of hypertension, anticoagulation strategies, and advanced heart failure therapies.
- Endocrinology: New generation GLP-1 agonists and SGLT2 inhibitors in the management of Type 2 Diabetes.
- Infectious Disease: Current antibiotic stewardship guidelines and treatment protocols for multi-drug resistant organisms.
- Neurology and Psychiatry: Advanced management of seizure disorders and pharmacologic interventions for mood disorders.
With 30 months of access, you can complete the requirements at your own pace while ensuring your clinical knowledge remains current with the latest FDA approvals and clinical guidelines.
The 100-Hour PANRE Review Course: Comprehensive Preparation
If your certification cycle is nearing its end, the PANRE Review Course offers a more robust solution. This course provides 100 hours of AAPA Category 1 Credit. While the Pharmacology course is focused strictly on medication management, the PANRE Review course encompasses the full breadth of the NCCPA Blueprint.
This package includes 1,672 board-style questions and covers essential specialties:
- Emergency Medicine
- Internal Medicine and Hospitalist medicine
- Orthopedics and Dermatology
- OB/GYN and Cardiology
The 100-hour package is the most efficient way to satisfy your entire Category 1 requirement in a single program. Like our other offerings, this course grants 30 months of access, allowing you to revisit the material as you prepare for your exam or seek clinical refreshers in specific body systems.
Enriching Your Education with Gift Card Add-Ons
We understand that PAs often have CME stipends that must be utilized by a specific date, or they risk losing that funding. For many buyers, June 30th is the final cutoff to use remaining 2026 CME stipend dollars before a July 1 reset or budget expiration. To help you maximize the value of your professional development budget before that deadline, we offer CME with Gift Card add-ons.
You can add an Amazon or Apple Gift Card ranging from $100 to $1,500 to your purchase. This allows you to secure the high-quality AAPA Category 1 Pharmacology Credit you need before June 30th while also obtaining funds to purchase additional clinical resources, medical equipment, or technology to support your practice. The total package price reflects the cost of the educational content and the selected gift card value, providing a streamlined way to use your 2026 CME allowance before the mid-year deadline passes.
Clinical Practice: Pharmacology & PANRE Assessment
Test your knowledge with these board-style vignettes. These scenarios reflect the type of content found within our 1,672-question bank.
Scenario 1: Cardiovascular Management
Your patient is a 64-year-old male with a history of hypertension and chronic kidney disease (Stage 3). He presents for a routine follow-up. His current medications include Lisinopril 20mg daily and Amlodipine 10mg daily. Today, his blood pressure is 152/94 mmHg. His potassium level is 4.8 mEq/L and his Serum Creatinine is 1.8 mg/dL (stable from baseline). You decide to add a third agent.
Which of the following is the most appropriate next step in pharmacologic management?
A) Increase Lisinopril to 40mg daily
B) Add Chlorthalidone 12.5mg daily
C) Add Spironolactone 25mg daily
D) Add Losartan 50mg daily
Correct Answer: B) Add Chlorthalidone 12.5mg daily
Thiazide-like diuretics, specifically Chlorthalidone, are recommended as a preferred third-line agent in patients with uncontrolled hypertension, even in those with moderate CKD (CrCl >30 mL/min). Increasing the ACE inhibitor (Lisinopril) is less likely to achieve the target BP than adding a different class of medication. Adding an ARB (Losartan) to an ACE inhibitor is contraindicated due to the increased risk of hyperkalemia and acute kidney injury. Spironolactone is a potent antihypertensive but carries a significant risk of hyperkalemia in patients already on an ACE inhibitor with CKD.
Scenario 2: Endocrine Intervention
Your patient is a 52-year-old female with Type 2 Diabetes and a BMI of 34. Her latest HbA1c is 8.2% despite adherence to Metformin 1000mg BID. She has no history of cardiovascular disease but is concerned about weight gain.
Which of the following medications provides the greatest benefit for both glycemic control and weight loss?
A) Glipizide
B) Pioglitazone
C) Semaglutide
D) Sitagliptin
Correct Answer: C) Semaglutide
Semaglutide is a GLP-1 receptor agonist that offers significant HbA1c reduction and superior weight loss compared to other options. Glipizide (a sulfonylurea) and Pioglitazone (a TZD) are both associated with weight gain. Sitagliptin (a DPP-4 inhibitor) is weight-neutral and generally provides less robust HbA1c lowering than GLP-1 agonists.
Scenario 3: Infectious Disease
Your patient is a 28-year-old female presenting with dysuria, urgency, and suprapubic pain for two days. She denies fever, chills, or flank pain. She has no known drug allergies and has not taken antibiotics in the last six months. A point-of-care urinalysis is positive for nitrites and leukocyte esterase.
What is the first-line treatment for this patient’s uncomplicated cystitis?
A) Ciprofloxacin 250mg BID for 3 days
B) Nitrofurantoin 100mg BID for 5 days
C) Amoxicillin 500mg TID for 7 days
D) Cephalexin 500mg BID for 7 days
Correct Answer: B) Nitrofurantoin 100mg BID for 5 days
Nitrofurantoin, Trimethoprim-sulfamethoxazole, and Fosfomycin are the recommended first-line agents for uncomplicated urinary tract infections. Fluoroquinolones like Ciprofloxacin should be reserved for more complicated infections or when first-line agents cannot be used due to the risk of significant side effects (tendon rupture, C. diff). Amoxicillin and Cephalexin have higher rates of resistance and are less effective for empirical treatment of cystitis.
Strategic Planning for the June 30th Deadline
Maintaining your credentials requires proactive management of your CME requirements. By choosing a course that offers 30 months of access, you ensure that you are covered not just for the immediate June 30th sprint, but well into the next certification cycle.
Whether you need the 12 hours of Category 1 Pharmacology Credit or the comprehensive 100 hours of AAPA Category 1 Credit for the PANRE, CME Review Courses provides the flexibility and depth required by modern PAs. The immediate issue, however, is the calendar: June 30th is the final cutoff for many clinicians to secure AAPA Category 1 Pharmacology Credit for mid-year needs and to spend remaining 2026 stipend funds before they are forfeited or reset. By integrating Amazon and Apple gift card add-ons, you can use that budget efficiently while meeting your CME goals.
Do not wait until the final week of June if your employer, license cycle, or credentialing process runs on a mid-year deadline. Secure your Pharmacology Credit and use your 2026 stipend before June 30th. Review the NCCPA Blueprint content areas and secure your credits today.